Dow Up 0.08% Nasdaq Down 0.30%

Lpath Inc. (LPTN)

-NasdaqCM
3.20 Down 0.16(4.76%) Sep 19, 4:00PM EDT
Prev Close:3.36
Open:3.42
Bid:3.15 x 10000
Ask:N/A
1y Target Est:14.00
Beta:0.39
Next Earnings Date:N/A
Day's Range:3.20 - 3.42
52wk Range:2.75 - 6.10
Volume:112,835
Avg Vol (3m):58,327
Market Cap:49.98M
P/E (ttm):N/A
EPS (ttm):-0.63
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LPTN

Key Statistics

Forward P/E (1 yr):80.00
P/S (ttm):6.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.13
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lpath, Inc., a biotechnology company, focuses on the discovery and development of lipidomic-based therapeutic antibodies for treating a range of human diseases primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback